ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -23 مورد

Antiemetic medication dosing for management of nausea and vomiting of pregnancy

Antiemetic medication dosing for management of nausea and vomiting of pregnancy
Drug Dose Comments
Vitamins
Pyridoxine (vitamin B6)*
  • 10 to 25 mg orally every 6 to 8 hours, PRN.
  • Where the 10 mg tablet is unavailable, the 25 mg tablet can be used safely (splitting the tablet can be difficult).
Antihistamines (H1 antagonists)
Doxylamine-pyridoxine
  • Two extended-release tablets orally at bedtime (each tablet contains doxylamine 10 mg and pyridoxine 10 mg).
  • May increase to four tablets orally over the course of the day for more severe nausea (two tablets at bedtime, one tablet midmorning and one tablet in midafternoon if needed).
  • A higher dose extended-release tablet containing 20 mg of doxylamine and 20 mg of pyridoxine is also available. One of these tablets is taken orally at bedtime, and if symptoms persist into the next day, one additional tablet is taken in the morning.
  • Taken daily (ie, not PRN)
  • Doxylamine and pyridoxine may be taken separately. Doxylamine is available in some over-the-counter sleeping pills (eg, Unisom Sleep Tabs) and as a prescription antihistamine chewable tablet (eg, Aldex AN): One-half of the 25 mg over-the-counter tablet or two chewable 5 mg tablets can be used off-label as an antiemetic. Pyridoxine (vitamin B-6) 25 mg, also available over-the-counter, can be taken three or four times per day along with 12.5 mg of doxylamine (the 10 mg dose of pyridoxine is not commercially available in the United States).
Diphenhydramine
  • 25 mg orally, IV, or IM every 4 to 6 hours. Increase to 50 mg orally, IV, or IM every 6 to 8 hours, PRN.
  • If the patient is taking doxylamine, the total dose of diphenhydramine should not exceed 100 mg/day.
Dimenhydrinate
  • 25 to 50 mg orally every 4 to 6 hours, PRN.
  • 50 mg IV or rectally (where available) every 4 to 6 hours, PRN.
  • If the patient is taking doxylamine, the total dose of dimenhydrinate should not exceed 200 mg/day.
Dopamine antagonistsΔ
Metoclopramide
  • 5 to 10 mg orally, IV, or IM every 6 to 8 hours, PRN.
  • Preferably given 30 minutes before meals and bedtime.
  • Rarely causes tardive dyskinesia with prolonged use.
Promethazine
  • 12.5 to 25 mg orally, rectally, or IM every 4 hours, PRN.
  • When parenteral therapy is indicated, other parenteral antiemetics with less risk of tissue injury and other adverse effects are preferred (eg, prochlorperazine, diphenhydramine).
Prochlorperazine
  • 5 to 10 mg orally, IV, or IM every 6 to 8 hours, PRN.
  • 25 mg rectally every 12 hours, PRN.
 
Chlorpromazine
  • 25 to 50 mg IV or IM every 4 to 6 hours, PRN.
  • 10 to 25 mg orally every 4 to 6 hours, PRN.
  • More frequent and severe adverse effects than other dopamine antagonists.
  • Typically reserved for refractory symptoms in patients who cannot tolerate steroids.
Serotonin antagonist
Ondansetron
  • 4 mg orally or IV every 8 hours, PRN. May increase to 8 mg orally or IV every 8 to 12 hours, PRN.
  • An orally disintegrating tablet is available (may be tolerated even in the setting of nausea and vomiting).
  • Potentially serious side effects.
Glucocorticoids
Methylprednisolone
  • 125 mg IV followed by oral prednisone tapered over 2 weeks: prednisone 40 mg on the first day, followed by 20 mg daily for three days, followed by 10 mg daily for three days, and then 5 mg daily for seven days,
  • or
  • 16 mg orally every 8 hours for three days followed by an oral tapering regimen (halve the dose every three days over 2 weeks).
  • Reserved for refractory symptoms.
  • May be stopped abruptly if no response within 72 hours.
Hydrocortisone
  • 100 mg IV every 8 hours for 72 hours followed by an IV tapering regimen (200 mg IV for two days and then 100 mg IV for another two days).
Adjunctive acid-reducing medications for patients with reflux/heartburn
Esomeprazole
  • 40 mg IV once daily.
  • 20 to 40 mg orally daily or equivalent dosed oral PPI.
  • IV: No dosage adjustment necessary for any degree of kidney impairment.
  • Oral: For magnesium salt, no dosage adjustment is necessary for any degree of kidney dysfunction; for strontium salt, do not use in patients with eGFR <30 mL/minute/1.73 m2.§
Calcium- or aluminum-containing antacid
  • Calcium carbonate 1 to 4 tablets (approximately 500 to 1250 mg calcium carbonate per tablet) or 5 to 10 mL (1250 mg per 5 mL) PRN.
  • Aluminum hydroxide 640 mg orally 5 to 6 times daily after meals and at bedtime (maximum: 3840 mg in 24 hours).
  • Over the counter dosing recommendations vary by product and/or manufacturer; consult specific product labeling.
Histamine 2 receptor antagonist (eg, cimetidine, famotidine)
  • Cimetidine 200 to 400 mg orally twice daily.
  • Famotidine 10 to 20 mg orally twice daily.
  • Adjust cimetidine dose in patients with GFR <50 mL/minute.§
  • Adjust famotidine dose in patients with CrCl <60 mL/minute.§
Typically one antiemetic medication is scheduled and a second from a different category is administered as needed for breakthrough symptoms. Some patients with severe or refractory symptoms may require two or more scheduled antiemetics. All of these medications have generally reassuring maternal and fetal safety profiles, but the quality of available data varies by medication. Refer to UpToDate content on nausea and vomiting of pregnancy for information on medication choice, side effects, and fetal safety data.

CrCl: creatinine clearance; eGFR: estimated glomerular filtration rate; GFR: glomerular filtration rate; IM: intramuscularly; IV: intravenously; NVP: nausea and vomiting of pregnancy; PRN: as needed.

* Supplements manufactured according to current good manufacturing practices (cGMPs) and other relevant quality standards can be identified by USP labeling (https://www.usp.org/verification-services/verified-mark).

¶ Common side effects of antihistamines include sedation, dry mouth, lightheadedness, and constipation.

Δ Main maternal adverse effects include sedation and risk of dystonic reactions.

◊ Refer to UpToDate content on treatment of nausea and vomiting in pregnancy for detailed information on potentially serious side effects and other issues.

§ Refer to UpToDate drug information for detailed information on drug dosing in patients with kidney impairment.

Graphic 140999 Version 6.0